1. A novel preservative‐free seasonal influenza vaccine safety and immune response study in the frame of preclinical research. Issue 7 (28th March 2017) Authors: Sarsenbayeva, Gulbanu; Volgin, Yevgeniy; Kassenov, Markhabat; Issagulov, Timur; Bogdanov, Nikolay; Nurpeisova, Ainur; Sagymbay, Altynay; Abitay, Ruslan; Stukova, Marina; Sansyzbay, Abylay; Khairullin, Berik Journal: Journal of medical virology Issue: Volume 89:Issue 7(2017) Page Start: 1168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of an inactivated whole-virion vaccine against COVID-19, QazCovid-in®, in healthy adults: A multicentre, randomised, single-blind, placebo-controlled phase 3 clinical trial with a 6-month follow-up. (August 2022) Authors: Khairullin, Berik; Zakarya, Kunsulu; Orynbayev, Mukhit; Abduraimov, Yergali; Kassenov, Markhabat; Sarsenbayeva, Gulbanu; Sultankulova, Kulyaisan; Chervyakova, Olga; Myrzakhmetova, Balzhan; Nakhanov, Aziz; Nurpeisova, Ainur; Zhugunissov, Kuandyk; Assanzhanova, Nurika; Nurabayev, Sergazy; Kerimbaye... Journal: EClinicalMedicine Issue: Volume 50(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Immunogenicity and safety of a novel seasonal influenza preservative-free vaccine manufactured in Kazakhstan: Results of a randomized, comparative, phase II clinical trial in adults. Issue 3 (4th March 2018) Authors: Sarsenbayeva, Gulbanu; Volgin, Yevgeniy; Kassenov, Markhabat; Issagulov, Timur; Bogdanov, Nikolay; Sansyzbay, Abylay; Stukova, Marina; Buzitskaya, Zhanna; Кulmagambetov, Ilyas; Davlyatshin, Timur; Khairullin, Berik Journal: Human vaccines & immunotherapeutics Issue: Volume 14:Issue 3(2018) Page Start: 609 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Safety and immunogenicity of a QazCovid-in® inactivated whole-virion vaccine against COVID-19 in healthy adults: A single-centre, randomised, single-blind, placebo-controlled phase 1 and an open-label phase 2 clinical trials with a 6 months follow-up in Kazakhstan. (September 2021) Authors: Zakarya, Kunsulu; Kutumbetov, Lespek; Orynbayev, Mukhit; Abduraimov, Yergali; Sultankulova, Kulyaisan; Kassenov, Markhabat; Sarsenbayeva, Gulbanu; Kulmagambetov, Ilyas; Davlyatshin, Timur; Sergeeva, Maria; Stukova, Marina; Khairullin, Berik Journal: EClinicalMedicine Issue: Volume 39(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Safety and immunogenicity of the first Kazakh inactivated vaccine for COVID-19. Issue 5 (30th November 2022) Authors: Nurpeisova, Ainur; Khairullin, Berik; Abitaev, Ruslan; Shorayeva, Kamshat; Jekebekov, Kuanish; Kalimolda, Elina; Kerimbayev, Aslan; Akylbayeva, Karligash; Abay, Zhandos; Myrzakhmetova, Balzhan; Nakhanov, Aziz; Absatova, Zharkinay; Nurabayev, Sergazy; Orynbayev, Mukhit; Assanzhanova, Nurika; Abeuo... Journal: Human vaccines & immunotherapeutics Issue: Volume 18:Issue 5(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Safety and immunogenicity of the novel seasonal preservative‐ and adjuvant‐free influenza vaccine: Blind, randomized, and placebo‐controlled trial. Issue 1 (25th September 2017) Authors: Sarsenbayeva, Gulbanu; Volgin, Yevgeniy; Kassenov, Markhabat; Issagulov, Timur; Bogdanov, Nikolay; Sansyzbay, Abylay; Abitay, Ruslan; Nurpeisova, Ainur; Sagymbay, Altynay; Koshemetov, Zhumagali; Stukova, Marina; Buzitskaya, Zhanna; Кulmagambetov, Ilyas; Karabayeva, Dinara; Davlyatshin, Timur; Kha... Journal: Journal of medical virology Issue: Volume 90:Issue 1(2018) Page Start: 41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Safety and immunogenicity of trivalent inactivated influenza vaccine in adults 60 years of age and older: a phase II, a randomized, comparative trial in Kazakhstan. Issue 8 (2nd August 2020) Authors: Sarsenbayeva, Gulbanu; Issagulov, Timur; Kassenov, Markhabat; Abitay, Ruslan; Orynbayev, Mukhit; Stukova, Marina; Pisareva, Maria; Davlyatshin, Timur; Lespek, Kutumbetov; Khairullin, Berik Journal: Human vaccines & immunotherapeutics Issue: Volume 16:Issue 8(2020) Page Start: 1791 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Safety and immunogenicity of trivalent inactivated influenza vaccine in adults 60 years of age and older: a phase II, a randomized, comparative trial in Kazakhstan. Issue 8 (2nd August 2020) Authors: Sarsenbayeva, Gulbanu; Issagulov, Timur; Kassenov, Markhabat; Abitay, Ruslan; Orynbayev, Mukhit; Stukova, Marina; Pisareva, Maria; Davlyatshin, Timur; Lespek, Kutumbetov; Khairullin, Berik Journal: Human vaccines & immunotherapeutics Issue: Volume 16:Issue 8(2020) Page Start: 1791 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗